I’m sure he “cares”. But it probably makes little difference to him right now. Whether the price is .20, .30, or .50, he’s not going to raise funds off of this stock.
As far as the comment about whether the company will exist when the science is complete, that is a good Q. But same point as above. Whether the SP is at .50 or .05, Joe has the funds he’s going to get for now.
He is either going to secure a CV deal that brings in some cash or spin NGIO to jump start this thing or he’s not. It has never been more critical that he make something real happen. The fork in the road is approaching, and one leads to a cliff...
Generex Biotechnology Corp. (GNBT) Stock Research Links